ATE426169T1 - Fruher nachweis einer lysosomalen speicher- krankheit - Google Patents

Fruher nachweis einer lysosomalen speicher- krankheit

Info

Publication number
ATE426169T1
ATE426169T1 AT97920460T AT97920460T ATE426169T1 AT E426169 T1 ATE426169 T1 AT E426169T1 AT 97920460 T AT97920460 T AT 97920460T AT 97920460 T AT97920460 T AT 97920460T AT E426169 T1 ATE426169 T1 AT E426169T1
Authority
AT
Austria
Prior art keywords
lysosomal storage
early detection
storage disease
detection
lamp
Prior art date
Application number
AT97920460T
Other languages
English (en)
Inventor
Peter Meikle
Douglas Brooks
John Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Application granted granted Critical
Publication of ATE426169T1 publication Critical patent/ATE426169T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT97920460T 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit ATE426169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders

Publications (1)

Publication Number Publication Date
ATE426169T1 true ATE426169T1 (de) 2009-04-15

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920460T ATE426169T1 (de) 1996-05-17 1997-05-16 Fruher nachweis einer lysosomalen speicher- krankheit

Country Status (10)

Country Link
US (2) US6759189B1 (de)
EP (1) EP1021725B1 (de)
JP (3) JP3837711B2 (de)
AT (1) ATE426169T1 (de)
AU (1) AUPN991796A0 (de)
CA (2) CA2731490A1 (de)
DE (1) DE69739317D1 (de)
IL (1) IL127033A (de)
NZ (1) NZ332641A (de)
WO (1) WO1997044668A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
JP2003514216A (ja) * 1999-04-30 2003-04-15 ザ ナタン エス． クライン インスティテュート フォー サイキアトリック リサーチ ニューロン萎縮関連痴呆の治療法
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
CN102137926A (zh) * 2006-12-13 2011-07-27 Tgr生物科学私人有限公司 促进由成纤维细胞生成ecm和/或促进生物体系中成纤维细胞迁移
CA2718182A1 (en) * 2008-03-12 2009-09-17 Amicus Therapeutics, Inc. Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
CA2147887A1 (en) * 1992-10-30 1994-05-11 James W. Dennis Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
IL127033A (en) 2000-12-06
JP4260152B2 (ja) 2009-04-30
AUPN991796A0 (en) 1996-06-13
US6759189B1 (en) 2004-07-06
JP3837711B2 (ja) 2006-10-25
DE69739317D1 (de) 2009-04-30
IL127033A0 (en) 1999-09-22
CA2731490A1 (en) 1997-11-27
EP1021725A4 (de) 2002-10-30
JP2006061161A (ja) 2006-03-09
EP1021725A1 (de) 2000-07-26
CA2253875A1 (en) 1997-11-27
JP2001519894A (ja) 2001-10-23
JP2008289501A (ja) 2008-12-04
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
EP1021725B1 (de) 2009-03-18
NZ332641A (en) 2000-05-26
CA2253875C (en) 2011-02-22

Similar Documents

Publication Publication Date Title
ATE426169T1 (de) Fruher nachweis einer lysosomalen speicher- krankheit
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2184266T3 (es) Preparacion enzimatica liquida y su empleo.
BR9914044A (pt) ésteres tetrahidropirido
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2091737T3 (es) Formulaciones farmaceuticas de fluoxetina.
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
BR0200571A (pt) Produtos de legumes
BR9808140A (pt) Formulação unitária
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
CA2271544A1 (en) Method to detect bone and other connective tissue disorders in humans and animals
FR2809000B1 (fr) Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution
WO2003001182A3 (en) Homocysteinylated transthyretin
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
BR9814188A (pt) "agonistas de 5-ht1f"
DK0853476T3 (da) Nimesulidholdigt farmaceutisk præparat til topisk anvendelse
DE69831737D1 (de) Neurotrypsin
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
WO1999050671A3 (en) Toso as a target for drug screening
WO1999016887A3 (en) Compositions and methods for identifying pkb kinase inhibitors
EA199900723A1 (ru) Производные феноксиуксусной кислоты и их применение в качестве гербицидов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties